ClinicalTrials.gg
Not yet recruitingNCT07665775Updated Jun 24, 2026

Effectiveness of an Inpatient Rehabilitation and Prosthetic Training Model in Patients With Vascular and Metabolic Transfemoral Amputation

An observational study in Diabetes Mellitus, Transfemoral Amputation and Peripheral Arterial Disease, sponsored by Instituto Nacional de Rehabilitacion. Not yet recruiting at 1 site in Mexico. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-24.

Sponsored by Instituto Nacional de Rehabilitacion · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
54
Ages
18 Years and older
Sex
All
01

Study summary

Patients with vascular and metabolic transfemoral amputations experience substantial functional limitations and high rates of prosthetic abandonment. Although multidisciplinary inpatient rehabilitation programs have been associated with improved outcomes, evidence regarding their effectiveness in low- and middle-income countries remains limited.

This study aims to evaluate the effectiveness of an inpatient rehabilitation and prosthetic training model implemented at the National Institute of Rehabilitation "Luis Guillermo Ibarra Ibarra" (INRLGII), Mexico. An ambispective cohort design will be used, including a retrospective review of patients treated between 2013 and 2025 and a prospective cohort enrolled between 2026 and 2029.

The primary objective is to determine the proportion of patients who achieve functional prosthesis use after hospital discharge. Secondary objectives include identifying clinical, metabolic, functional, and psychosocial factors associated with successful prosthetic use, adherence, and abandonment.

Read the detailed description

Background

Diabetes mellitus and peripheral vascular disease are major causes of lower-limb amputation worldwide. Transfemoral amputation is associated with substantial disability, increased energy expenditure during ambulation, reduced mobility, and decreased quality of life. Despite advances in prosthetic technology, long-term prosthetic use remains challenging, with reported abandonment rates ranging from 30% to 60%.

The National Institute of Rehabilitation "Luis Guillermo Ibarra Ibarra" (INRLGII) has developed a multidisciplinary inpatient rehabilitation and prosthetic training model for patients with vascular and metabolic amputations. The program integrates rehabilitacion medicine, physical therapy, occupational therapy, psychology, cardiopulmonary evaluation, biomedical engineering, and prosthetic fabrication in a coordinated inpatient setting.

Although international evidence suggests that inpatient multidisciplinary rehabilitation improves functional outcomes and prosthetic success, no institutional or national studies have systematically evaluated the effectiveness of this model in Mexican patients with vascular and metabolic transfemoral amputation.

Objective

To evaluate the effectiveness of an inpatient multidisciplinary rehabilitation and prosthetic training model in patients with unilateral transfemoral amputation of vascular or metabolic etiology.

Study Design

This is an observational, longitudinal, ambispective cohort study.

The retrospective phase will include patients treated between 2013 and 2025 through review of electronic medical records.

The prospective phase will include consecutive patients enrolled between 2026 and 2029. Functional prosthesis use will be assessed at 3 and 6 months after discharge using the Houghton Scale and structured recording of daily prosthesis use.

Hypothesis

The inpatient rehabilitation and prosthetic training model is associated with a higher proportion of functional prosthesis use at 6 months compared with rates reported in the international literature for vascular and metabolic transfemoral amputees

02

Conditions studied

  • Diabetes Mellitus
  • Transfemoral Amputation
  • Peripheral Arterial Disease
  • Vascular Thrombosis

Keywords

  • Transfemoral Amputation
  • Vascular Amputation
  • Diabetes Mellitus
  • Prosthetic Rehabilitation
  • Lower Limb Amputation
  • Prosthesis Use
  • Prosthetic Adherence
  • Prosthetic Abandonment
  • Functional Outcomes
  • Inpatient Rehabilitation
  • Multidisciplinary Care
  • Houghton Scale
03

In context

Diabetes Mellitus

8,290 studies on the registry are indexed under Diabetes Mellitus; 1,077 are open to participants now.

This study's planned enrollment of 54 is below the median of 246 across 1,936 observational studies indexed under Diabetes Mellitus.

Browse Diabetes Mellitus studies →

Lead sponsor

Instituto Nacional de Rehabilitacion is the lead sponsor of 19 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients (≥18 years) with unilateral transfemoral amputation secondary to vascular disease or diabetes-related complications who are treated through the inpatient prosthetic rehabilitation program at the National Institute of Rehabilitation Luis Guillermo Ibarra Ibarra (INRLGII), Mexico.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Unilateral transfemoral amputation secondary to vascular disease or diabetes-related complications.
  • Participation in the INRLGII inpatient prosthetic rehabilitation program.
  • Availability of complete clinical records or willingness to participate in follow-up assessments .
  • Signed .

Exclusion criteria

Exclusion Criteria:

  • Current prosthesis user before admission to the INRLGII rehabilitation program.
  • Bilateral major lower-limb amputation.
  • Inability to complete follow-up assessments.

Withdrawal Criteria

  • Incomplete or inconsistent clinical information.
  • Loss to follow-up during the 6-month observation period.
  • Participant withdrawal of consent.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
54 participants (estimated)
Target follow-up
6 Months
Patient registry
Yes

Groups and cohorts

  • Patients With Vascular or Metabolic Transfemoral Amputation Undergoing Inpatient Prosthetic Rehabili

    Adult patients with unilateral transfemoral amputation secondary to vascular disease or diabetes-related complications who participate in the inpatient prosthetic rehabilitation program at the National Institute of Rehabilitation Luis Guillermo Ibarra Ibarra (INRLGII). Participants will be evaluated for functional prosthesis use, adherence, and factors associated with successful prosthetic rehabilitation.

06

What researchers measure

Primary outcomes

  1. Functional Prosthesis Use at 6 Months

    Functional prosthesis use defined as prosthesis use ≥8 hours per day and a Houghton Scale score ≥9.

    Time frame: 6 months after hospital discharge.

Secondary outcomes

  1. Houghton Scale Score

    Functional mobility and prosthetic use assessed using the Houghton Scale (0-12 points).

    Time frame: Time Frame: 3 and 6 months after discharge.

  2. Daily Prosthesis Use

    Average number of hours per day the prosthesis is used.

    Time frame: 3 and 6 months after discharge.

  3. Factors Associated With Functional Prosthesis Use

    Association between functional use and demographic, clinical, metabolic, and psychosocial variables.

    Time frame: Baseline, 3 months, and 6 months.

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared because the dataset contains sensitive clinical information from a relatively small patient population, which may increase the risk of participant re-identification despite de-identification procedures. Data will be used exclusively for the purposes approved by the institutional ethics and research committees.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07665775
Lead sponsor
Instituto Nacional de Rehabilitacion
Responsible party
LAURA PAULINA MUÑOZ VELASCO (MD, Instituto Nacional de Rehabilitacion) — Principal investigator
First posted
Jun 24, 2026
Start date
Jun 19, 2026 (estimated)
Primary completion
Jun 2030 (estimated)
Completion
Sep 2030 (estimated)
Last update
Jun 24, 2026

Study contacts

LAURA PAULINA Muñoz Velasco, Medical Doctor
Contact
lpmunoz@gmail.com
+525559991000 ext. 13213

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion